vs

Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and Montrose Environmental Group, Inc. (MEG). Click either name above to swap in a different company.

ACADIA PHARMACEUTICALS INC is the larger business by last-quarter revenue ($268.1M vs $193.3M, roughly 1.4× Montrose Environmental Group, Inc.). ACADIA PHARMACEUTICALS INC runs the higher net margin — 1.4% vs -4.3%, a 5.6% gap on every dollar of revenue. On growth, ACADIA PHARMACEUTICALS INC posted the faster year-over-year revenue change (9.7% vs 2.2%). Over the past eight quarters, Montrose Environmental Group, Inc.'s revenue compounded faster (11.5% CAGR vs 5.3%).

Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.

Montrose Environmental Group, Inc. is an American multinational corporation that provides wide-ranging environmental services. The company is vertically integrated across the environmental industry and supports public and private sector clientele. Montrose is headquartered in Little Rock, Arkansas and incorporated in the U.S. state of Delaware.

ACAD vs MEG — Head-to-Head

Bigger by revenue
ACAD
ACAD
1.4× larger
ACAD
$268.1M
$193.3M
MEG
Growing faster (revenue YoY)
ACAD
ACAD
+7.5% gap
ACAD
9.7%
2.2%
MEG
Higher net margin
ACAD
ACAD
5.6% more per $
ACAD
1.4%
-4.3%
MEG
Faster 2-yr revenue CAGR
MEG
MEG
Annualised
MEG
11.5%
5.3%
ACAD

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ACAD
ACAD
MEG
MEG
Revenue
$268.1M
$193.3M
Net Profit
$3.6M
$-8.2M
Gross Margin
38.6%
Operating Margin
-1.7%
-1.3%
Net Margin
1.4%
-4.3%
Revenue YoY
9.7%
2.2%
Net Profit YoY
70.9%
EPS (diluted)
$0.02
$-0.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACAD
ACAD
MEG
MEG
Q1 26
$268.1M
Q4 25
$284.0M
$193.3M
Q3 25
$278.6M
$224.9M
Q2 25
$264.6M
$234.5M
Q1 25
$244.3M
$177.8M
Q4 24
$259.6M
$189.1M
Q3 24
$250.4M
$178.7M
Q2 24
$242.0M
$173.3M
Net Profit
ACAD
ACAD
MEG
MEG
Q1 26
$3.6M
Q4 25
$273.6M
$-8.2M
Q3 25
$71.8M
$8.4M
Q2 25
$26.7M
$18.4M
Q1 25
$19.0M
$-19.4M
Q4 24
$143.7M
$-28.2M
Q3 24
$32.8M
$-10.6M
Q2 24
$33.4M
$-10.2M
Gross Margin
ACAD
ACAD
MEG
MEG
Q1 26
Q4 25
90.8%
38.6%
Q3 25
92.2%
39.4%
Q2 25
92.2%
43.4%
Q1 25
91.7%
39.0%
Q4 24
91.6%
40.8%
Q3 24
92.5%
40.9%
Q2 24
92.5%
39.9%
Operating Margin
ACAD
ACAD
MEG
MEG
Q1 26
-1.7%
Q4 25
6.1%
-1.3%
Q3 25
12.8%
4.4%
Q2 25
12.2%
6.4%
Q1 25
7.9%
-5.9%
Q4 24
59.1%
-12.1%
Q3 24
12.6%
-0.6%
Q2 24
12.6%
-1.5%
Net Margin
ACAD
ACAD
MEG
MEG
Q1 26
1.4%
Q4 25
96.3%
-4.3%
Q3 25
25.8%
3.7%
Q2 25
10.1%
7.8%
Q1 25
7.8%
-10.9%
Q4 24
55.4%
-14.9%
Q3 24
13.1%
-5.9%
Q2 24
13.8%
-5.9%
EPS (diluted)
ACAD
ACAD
MEG
MEG
Q1 26
$0.02
Q4 25
$1.61
$-0.13
Q3 25
$0.42
$0.21
Q2 25
$0.16
$0.42
Q1 25
$0.11
$-0.64
Q4 24
$0.86
$-0.91
Q3 24
$0.20
$-0.39
Q2 24
$0.20
$-0.39

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACAD
ACAD
MEG
MEG
Cash + ST InvestmentsLiquidity on hand
$11.2M
Total DebtLower is stronger
$277.1M
Stockholders' EquityBook value
$451.2M
Total Assets
$1.6B
$981.3M
Debt / EquityLower = less leverage
0.61×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACAD
ACAD
MEG
MEG
Q1 26
Q4 25
$177.7M
$11.2M
Q3 25
$258.0M
$6.7M
Q2 25
$253.6M
$10.5M
Q1 25
$217.7M
$30.3M
Q4 24
$319.6M
$12.9M
Q3 24
$155.1M
$13.0M
Q2 24
$177.1M
$16.9M
Total Debt
ACAD
ACAD
MEG
MEG
Q1 26
Q4 25
$277.1M
Q3 25
$302.4M
Q2 25
$264.6M
Q1 25
$235.6M
Q4 24
$204.8M
Q3 24
$233.0M
Q2 24
$188.7M
Stockholders' Equity
ACAD
ACAD
MEG
MEG
Q1 26
Q4 25
$1.2B
$451.2M
Q3 25
$917.3M
$458.7M
Q2 25
$822.4M
$470.3M
Q1 25
$765.2M
$444.1M
Q4 24
$732.8M
$446.3M
Q3 24
$577.2M
$449.2M
Q2 24
$516.7M
$448.8M
Total Assets
ACAD
ACAD
MEG
MEG
Q1 26
$1.6B
Q4 25
$1.6B
$981.3M
Q3 25
$1.3B
$985.7M
Q2 25
$1.2B
$998.1M
Q1 25
$1.1B
$992.2M
Q4 24
$1.2B
$990.4M
Q3 24
$976.9M
$1.0B
Q2 24
$914.1M
$943.9M
Debt / Equity
ACAD
ACAD
MEG
MEG
Q1 26
Q4 25
0.61×
Q3 25
0.66×
Q2 25
0.56×
Q1 25
0.53×
Q4 24
0.46×
Q3 24
0.52×
Q2 24
0.42×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACAD
ACAD
MEG
MEG
Operating Cash FlowLast quarter
$51.9M
Free Cash FlowOCF − Capex
$46.5M
FCF MarginFCF / Revenue
24.1%
Capex IntensityCapex / Revenue
2.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$91.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACAD
ACAD
MEG
MEG
Q1 26
Q4 25
$-48.7M
$51.9M
Q3 25
$74.3M
$28.1M
Q2 25
$64.0M
$21.9M
Q1 25
$20.3M
$5.5M
Q4 24
$40.4M
$32.0M
Q3 24
$63.2M
$11.4M
Q2 24
$25.0M
$894.0K
Free Cash Flow
ACAD
ACAD
MEG
MEG
Q1 26
Q4 25
$46.5M
Q3 25
$73.9M
$22.3M
Q2 25
$19.9M
Q1 25
$2.4M
Q4 24
$29.7M
Q3 24
$63.2M
$10.2M
Q2 24
$-9.8M
FCF Margin
ACAD
ACAD
MEG
MEG
Q1 26
Q4 25
24.1%
Q3 25
26.5%
9.9%
Q2 25
8.5%
Q1 25
1.3%
Q4 24
15.7%
Q3 24
25.2%
5.7%
Q2 24
-5.6%
Capex Intensity
ACAD
ACAD
MEG
MEG
Q1 26
Q4 25
2.8%
Q3 25
0.1%
2.6%
Q2 25
0.8%
Q1 25
1.8%
Q4 24
1.2%
Q3 24
0.0%
0.6%
Q2 24
6.1%
Cash Conversion
ACAD
ACAD
MEG
MEG
Q1 26
Q4 25
-0.18×
Q3 25
1.03×
3.36×
Q2 25
2.40×
1.19×
Q1 25
1.07×
Q4 24
0.28×
Q3 24
1.93×
Q2 24
0.75×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons